{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:41:46Z","timestamp":1761100906498},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/cco.0b013e3282c8c8fc","type":"journal-article","created":{"date-parts":[[2007,8,6]],"date-time":"2007-08-06T07:04:46Z","timestamp":1186383886000},"page":"470-475","source":"Crossref","is-referenced-by-count":13,"title":["Human papillomavirus vaccines in HIV-positive men and women"],"prefix":"10.1097","volume":"19","author":[{"given":"Hugo","family":"De Vuyst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.20872","article-title":"HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas","volume":"115","author":"Kreimer","year":"2005","journal-title":"Int J Cancer"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"R5-10-20210128","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/156800907780006869","article-title":"Mechanisms used by human papillomaviruses to escape the host immune response","volume":"7","author":"Kanodia","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"issue":"Suppl 1","key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1440-1711.2000.00949.x","article-title":"Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences","volume":"78","author":"Natale","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","article-title":"TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16","volume":"178","author":"Hasan","year":"2007","journal-title":"J Immunol"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","article-title":"Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women","volume":"95","author":"Strickler","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/aje\/kwg171","article-title":"Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study","volume":"158","author":"Molano","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R13-10-20210128","first-page":"483","article-title":"Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide","volume":"11","author":"Kadish","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/0008-5472.CAN-06-3388","article-title":"High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer","volume":"67","author":"Piersma","year":"2007","journal-title":"Cancer Res"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0031-3955(05)70152-8","article-title":"Human papillomavirus infection in adolescents","volume":"46","author":"Moscicki","year":"1999","journal-title":"Pediatr Clin North Am"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in HIV-infected women","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"JAMA"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1258\/0956462991913583","article-title":"Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, Sao Paulo, Brazil","volume":"10","author":"Goncalves","year":"1999","journal-title":"Int J STD AIDS"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":"Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women","volume":"91","author":"Palefsky","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00002030-199809000-00013","article-title":"Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women","volume":"12","author":"Six","year":"1998","journal-title":"AIDS"},{"issue":"23","key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/oxfordjournals.jncimonographs.a024172","article-title":"Management of cervical neoplasia in human immunodeficiency virus-infected women.","author":"Maiman","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/sti.75.2.103","article-title":"Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE)","volume":"75","author":"Leroy","year":"1999","journal-title":"Sex Transm Infect"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0020-7292(99)00043-0","article-title":"Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection","volume":"65","author":"Temmerman","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00126334-200108150-00003","article-title":"Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study","volume":"27","author":"Massad","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0166-3542(03)00002-0","article-title":"Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants","volume":"58","author":"Shuman","year":"2003","journal-title":"Antiviral Res"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jnci\/djj010","article-title":"Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2","volume":"98","author":"Hawes","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/dji073","article-title":"Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women","volume":"97","author":"Strickler","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/00002030-200008180-00013","article-title":"Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women","volume":"14","author":"Delmas","year":"2000","journal-title":"AIDS"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jama.293.12.1471","article-title":"Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results","volume":"293","author":"Harris","year":"2005","journal-title":"JAMA"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/ijc.22015","article-title":"Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus","volume":"119","author":"Koshiol","year":"2006","journal-title":"Int J Cancer"},{"key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bjc.1998.610","article-title":"Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study","volume":"78","author":"Franceschi","year":"1998","journal-title":"Br J Cancer"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R34-10-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/1097-0215(20001101)88:3<489::AID-IJC25>3.0.CO;2-Q","article-title":"The spectrum of HIV-1 related cancers in South Africa","volume":"88","author":"Sitas","year":"2000","journal-title":"Int J Cancer"},{"key":"R35-10-20210128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ijc.21443","article-title":"Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS\u2013Cancer Registry Match Study","volume":"118","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"R36-10-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000226963.10342.f4","article-title":"High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men","volume":"20","author":"Sirera","year":"2006","journal-title":"AIDS"},{"key":"R38-10-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1529-8019.2005.05009.x","article-title":"Human papillomavirus anogenital disease in HIV-infected individuals","volume":"18","author":"Chin-Hong","year":"2005","journal-title":"Dermatol Ther"},{"key":"R39-10-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","article-title":"High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse","volume":"138","author":"Piketty","year":"2003","journal-title":"Ann Intern Med"},{"key":"R40-10-20210128","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","article-title":"Sexually transmitted infection as a cause of anal cancer","volume":"337","author":"Frisch","year":"1997","journal-title":"N Engl J Med"},{"key":"R41-10-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"R42-10-20210128","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"R43-10-20210128","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00126334-200412150-00004","article-title":"HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?","volume":"37","author":"Bower","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-10-20210128","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/aje\/kwm017","article-title":"The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS","volume":"165","author":"Hessol","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R45-10-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.amjsurg.2005.07.011","article-title":"Length of human immunodeficiency virus disease and not immune status is a risk factor for development of anal carcinoma","volume":"190","author":"Fagan","year":"2005","journal-title":"Am J Surg"},{"key":"R46-10-20210128","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.AOG.0000245786.86267.80","article-title":"Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer","volume":"108","author":"Hampl","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R47-10-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00432-006-0162-0","article-title":"Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile","volume":"133","author":"Hampl","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"R48-10-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(02)07368-3","article-title":"HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study","volume":"359","author":"Conley","year":"2002","journal-title":"Lancet"},{"key":"R49-10-20210128","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.AOG.0000210237.80211.ff","article-title":"Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus","volume":"107","author":"Jamieson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R50-10-20210128","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"R51-10-20210128","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4\u20135 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"R52-10-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R53-10-20210128","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"R55-10-20210128","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cgt.7700937","article-title":"Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine","volume":"13","author":"Garcia-Hernandez","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"R56-10-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","article-title":"ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial","volume":"103","author":"Garcia","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R57-10-20210128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.aids.0000226955.02719.26","article-title":"A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals","volume":"20","author":"Palefsky","year":"2006","journal-title":"AIDS"},{"issue":"Suppl 3","key":"R58-10-20210128","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.vaccine.2006.05.120","article-title":"Chapter 16: HPV vaccines in immunocompromised women and men","volume":"24","author":"Palefsky","year":"2006","journal-title":"Vaccine"},{"key":"R59-10-20210128","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/eji.200425547","article-title":"Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells","volume":"35","author":"Lenz","year":"2005","journal-title":"Eur J Immunol"},{"key":"R60-10-20210128","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"key":"R61-10-20210128","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.aids.0000183514.37513.d2","article-title":"CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults","volume":"19","author":"Cooper","year":"2005","journal-title":"AIDS"},{"key":"R62-10-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00431-006-0184-2","article-title":"Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART)","volume":"166","author":"Ching","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R63-10-20210128","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R64-10-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/dna.2006.25.277","article-title":"Antitumor therapeutic effects of e7 subunit and DNA vaccines in an animal cervical cancer model: antitumor efficacy of e7 therapeutic vaccines is dependent on tumor sizes, vaccine doses, and vaccine delivery routes","volume":"25","author":"Sin","year":"2006","journal-title":"DNA Cell Biol"},{"key":"R65-10-20210128","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"Taira","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R66-10-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/135965350400900117","article-title":"The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases","volume":"9","author":"Heard","year":"2004","journal-title":"Antivir Ther"},{"key":"R68-10-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/505219","article-title":"Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review","volume":"43","author":"Chiao","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0b013e3282c8c8fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T08:02:13Z","timestamp":1708156933000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-200709000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e3282c8c8fc","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}